The Munich-based holding company Mutares is navigating a confluence of events today that will test both its financial discipline and market credibility. A covenant verification deadline, a broken technical support level, and an insider share sale have all converged in the same week, while the group continues to advance a busy schedule of acquisitions and exits.
Covenant verdict arrives after year-long waiver
June 29 marks the end of a formal waiver that Mutares secured from its bondholders for the 2025 financial year via a written resolution. The company must now prove it has regained compliance with a key financial covenant tied to its outstanding bonds. Management has expressed confidence that the metric will not only be met but significantly beaten. The outcome is expected to influence the share price trajectory later today, with the stock already having slipped to €27.70 — a 3% decline ahead of the announcement.
Insider selling adds to technical pressure
Compounding the uncertainty, a member of the supervisory board, Dr.-Ing. Kristian Schleede, offloaded nearly 3,000 shares on June 19 at prices ranging from €29.15 to €29.225. The transaction was reported to BaFin on June 24, by which time the stock was still trading near that level. But the following days brought a sharp reversal: the share price fell to €27.95 by the close on June 26, and on that same day it breached the 200-day moving average of €28.95. The technical break accelerated selling pressure in the second half of the week. Year to date, Mutares sits roughly 23% below its 52-week high of €36.40. While the insider sale alone would not normally signal a shift in outlook, the combination with the technical breakdown has made investors particularly twitchy.
No-cash deal bolsters chemicals platform
Amid the noise, Mutares continues to expand its portfolio. It has agreed to acquire Synthomer a.s., a Czech producer of acrylate solutions used in construction chemicals, coatings, and adhesives, from Synthomer plc. The target generated around €110 million in revenue in 2025 and employs roughly 300 people. Reflecting Mutares’ typical deal structure, no upfront purchase price will be paid at closing. Instead, a cash-sharing arrangement of up to €12 million will be spread over three years. The transaction is expected to close by the end of the third quarter of 2026 and will strengthen the newly formed Chemicals & Materials segment. That division is also set to benefit from the planned acquisition of SABIC’s engineering thermoplastics business, which would be the largest takeover in the company’s history.
Exit pipeline: NEM Energy and Magirus in focus
On the divestment side, Mutares is selling NEM Energy B.V. to Hyundai Heavy Industries Power Systems. The business was originally acquired from Siemens Energy in December 2022 and has since been built into a standalone, profitable platform. The purchase price has not been disclosed. The deal is slated to close in the third quarter of 2026.
Should investors sell immediately? Or is it worth buying Mutares?
Another potential exit concerns Magirus, the firefighting specialist. Mutares is weighing a sale or an initial public offering for the unit, with a final decision dependent on market conditions. Magirus boasts an order backlog of more than €880 million, securing capacity deep into 2027. It generated about €336 million in revenue in 2025. The company’s defense arm, Magirus Defense, is also expanding following the acquisition of Achleitner Fahrzeugbau, pushing further into the military vehicle space.
Bond buyback plan and dividend proposal
To further strengthen its balance sheet, Mutares has laid out a plan to reduce its outstanding bond volume from €385 million to a maximum of €300 million. It intends to execute quarterly purchases of at least €25 million in bonds to achieve that target.
For the current financial year, management has guided for consolidated revenue of €7.9 billion to €9.1 billion and a holding-level net profit of €165 million to €200 million. For fiscal 2025, the board has proposed a minimum dividend of €2.00 per share, with an additional performance-linked dividend tied to successful exits.
The immediate focus, however, remains on today’s covenant result. If Mutares passes that test, the market will look to the second-half exit pipeline — starting with the NEM Energy closing and the next steps for Magirus — to restore investor confidence.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from June 29 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 29.
Mutares: Buy or sell? Read more here...
